Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of NK012 in Combination With Carboplatin in Patients With Advanced Solid Tumors Followed by a Dose Expansion Phase in Patients With Triple Negative Metastatic Breast Cancer

NCT01238952 is registered in ClinicalTrials.gov with Nippon Kayaku Co., Ltd. as lead sponsor.

NCT NCT01238952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01238952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of NK012 in Combination With Carboplatin in Patients With Advanced Solid Tumors Followed by a Dose Expansion Phase in Patients With Triple Negative Metastatic Breast Cancer
Lead sponsor
Nippon Kayaku Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2010
Completion date
March 31, 2013
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, metastatic triple negative breast cancer